scholarly journals Pulmonary Nontuberculous Mycobacterial Infection in Infants: A Systematic Review

2021 ◽  
Vol Volume 12 ◽  
pp. 551-559
Author(s):  
Alice Bai ◽  
Olivia Belda ◽  
Amrita Dosanjh
Keyword(s):  
Systematic Review ◽  
Mycobacterial Infection ◽  
Nontuberculous Mycobacterial Infection

Association between the use of inhaled corticosteroids and pulmonary nontuberculous mycobacterial infection: A systematic review

2020 ◽  
Vol 16 ◽  
Author(s):  
Mahnaz Mozdourian ◽  
Rozita Khodashahi
Keyword(s):  
Risk Factors ◽  
Systematic Review ◽  
Inhaled Corticosteroids ◽  
Mycobacterial Infection ◽  
Smoking History ◽  
Therapy Relationship ◽  
Increased Risk ◽  
Nontuberculous Mycobacterial Infection ◽  
History Of ◽  
Underlying Diseases

: The incidence of nontuberculous mycobacterial (NTM) pulmonary disease has increased in recent years. It seems that patients with structural lung diseases treated with inhaled corticosteroids (ICS) are at risk of pulmonary NTM infection. This systematic review investigated the articles focused on the association between the use of ICS and pulmonary NTM infection. The current study assessed four categories, namely the association between the use of ICS therapy and NTM infections, bacterial factors involved in the incidence of NTM infection in patients undergoing ICS therapy, relationship between dosage and long-term use of ICS therapy in the incidence of NTM infection, and main risk factors of the incidence of NTM infection in patients undergoing ICS therapy. Based on the obtained results of the present study, there was an association between the use of ICS therapy and NTM infections. It seems that ICS increases the risk of NTM infection by 1.8 to 8 times. Accordingly, 40-90% of patients with NTM had a history of ICS usage. Mycobacterium avium complex was the most common bacterial factor in NTM patients undergoing ICS therapy. The relationship between a higher dosage of ICS therapy and increased risk of NTM was confirmed in the majority of the studies. Age, gender, smoking history, and underlying diseases are the main risk factors for the incidence of NTM in patients receiving ICS therapy.

Nontuberculous mycobacterial infection in young children with cystic fibrosis

2005 ◽  
Vol 40 (1) ◽  
pp. 39-44 ◽  
Author(s):  
Charles R. Esther ◽  
Marianna M. Henry ◽  
Paul L. Molina ◽  
Margaret W. Leigh
Keyword(s):  
Cystic Fibrosis ◽  
Young Children ◽  
Mycobacterial Infection ◽  
Nontuberculous Mycobacterial Infection

Tuberculous and Nontuberculous Mycobacterial Infection of the Pancreas in a Patient with AIDS

Pancreas ◽  
1996 ◽  
Vol 12 (4) ◽  
pp. 412-413 ◽  
Author(s):  
EUGENE ALBU ◽  
ARSHAD M. YOUSUF ◽  
KRISHNASWAMY SWAMINATHAN ◽  
VIRENDRA PARIKH ◽  
PAUL H. GERST
Keyword(s):  
Mycobacterial Infection ◽  
Nontuberculous Mycobacterial Infection
Sign in / Sign up

Export Citation Format

Share Document